Capstone Asset Management’s Novartis NVS Stock Holding History

Capstone Asset Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$10.1M	Sell	134,788 -8,395	-6%	-$595K	0.28%	81
2017 Q1	$9.53M	Buy	143,183 +10,055	+8%	+$670K	0.27%	88
2016 Q4	$8.69M	Buy	133,128 +4,125	+3%	+$268K	0.25%	95
2016 Q3	$9.13M	Buy	129,003 +766	+0.6%	+$55.8K	0.26%	83
2016 Q2	$9.48M	Buy	128,237 +2,907	+2%	+$201K	0.29%	75
2016 Q1	$8.13M	Buy	125,330 +874	+0.7%	+$59.5K	0.23%	107
2015 Q4	$9.6M	Buy	124,456 +9,941	+9%	+$790K	0.28%	88
2015 Q3	$9.43M	Sell	114,515 -2,469	-2%	-$220K	0.29%	82
2015 Q2	$10.3M	Buy	116,984 +718	+0.6%	+$65.9K	0.3%	86
2015 Q1	$10.3M	Buy	116,266 +30,468	+36%	+$2.7M	0.29%	77
2014 Q4	$7.12M	Buy	85,798 +15,724	+22%	+$1.3M	0.21%	121
2014 Q3	$5.91M	Buy	70,074 +480	+0.7%	+$38.8K	0.2%	117
2014 Q2	$5.64M	Buy	69,594 +1,206	+2%	+$94.9K	0.18%	130
2014 Q1	$5.21M	Buy	68,388 +2,254	+3%	+$164K	0.16%	149
2013 Q4	$4.76M	Buy	66,134 +3,526	+6%	+$245K	0.14%	177
2013 Q3	$4.3M	Buy	62,608 +4,933	+9%	+$326K	0.1%	213
2013 Q2	$3.65M	Buy	+57,675	New	+$3.75M	0.1%	228

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Capstone Asset Management's NVS Position: Q2 2017 in Review

Capstone Asset Management reduced its Novartis (NVS) stake by 5.9% in Q2 2017, selling an estimated $595K and leaving 134,788 shares worth $10.1M. The position accounts for 0.28% of the portfolio, ranked #81.

Capstone Asset Management first reported a position in NVS in Q2 2013 and has held it in 17 quarters since. The position peaked at $10.3M in Q2 2015. 920 funds tracked by Wall St. Rank hold NVS as of Q2 2017.

Capstone Asset Management held 134,788 shares of Novartis worth $10.1M as of Q2 2017.
Capstone Asset Management sold 8,395 Novartis shares in Q2 2017, an estimated $595K.
Novartis made up 0.28% of Capstone Asset Management's portfolio in Q2 2017, its #81 holding.
Capstone Asset Management first reported a position in Novartis in Q2 2013 and has held it in 17 quarters since.
Capstone Asset Management's Novartis position peaked at $10.3M in Q2 2015.
920 funds tracked by Wall St. Rank held Novartis as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.